Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpak Chatterjee

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
ISBT Science Series|July 6, 2021
A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centreDurba Biswas, Chikam Maiti, Biplabendu Talukder, et al.
Plos One|September 17, 2009
A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cellsShilpak Chatterjee, Ananda Mookerjee, Jayati Mookerjee Basu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell ResponseShilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, et al.
The Journal of Biological Chemistry|April 12, 2019
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cellsParamita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, et al.
Cancer Research|July 29, 2016
Lack of p53 Augments Antitumor Functions in Cytolytic T CellsAnirban Banerjee, Krishnamurthy Thyagarajan, Shilpak Chatterjee, et al.
Cell Reports|August 15, 2019
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor ActivityParamita Chakraborty, Silvia G Vaena, Krishnamurthy Thyagarajan, et al.
Cancer Research|April 11, 2022
Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell FunctionParamita Chakraborty, Rasesh Y Parikh, Seungho Choi, et al.
The Journal of Infectious Diseases|August 16, 2021
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19Purbita Bandopadhyay, Ranit D'Rozario, Abhishake Lahiri, et al.
Frontiers in Immunology|November 15, 2021
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19Jafar Sarif, Deblina Raychaudhuri, Ranit D'Rozario, et al.
Nature Communications|June 2, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axisParamita Chakraborty, Shilpak Chatterjee, Mohamed Faisal Kassir, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
ISBT Science Series|July 6, 2021
A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centreDurba Biswas, Chikam Maiti, Biplabendu Talukder, et al.
Plos One|September 17, 2009
A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cellsShilpak Chatterjee, Ananda Mookerjee, Jayati Mookerjee Basu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell ResponseShilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, et al.
The Journal of Biological Chemistry|April 12, 2019
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cellsParamita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, et al.
Cancer Research|July 29, 2016
Lack of p53 Augments Antitumor Functions in Cytolytic T CellsAnirban Banerjee, Krishnamurthy Thyagarajan, Shilpak Chatterjee, et al.
Cell Reports|August 15, 2019
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor ActivityParamita Chakraborty, Silvia G Vaena, Krishnamurthy Thyagarajan, et al.
Cancer Research|April 11, 2022
Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell FunctionParamita Chakraborty, Rasesh Y Parikh, Seungho Choi, et al.
The Journal of Infectious Diseases|August 16, 2021
Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19Purbita Bandopadhyay, Ranit D'Rozario, Abhishake Lahiri, et al.
Frontiers in Immunology|November 15, 2021
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19Jafar Sarif, Deblina Raychaudhuri, Ranit D'Rozario, et al.
Nature Communications|June 2, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axisParamita Chakraborty, Shilpak Chatterjee, Mohamed Faisal Kassir, et al.
Pageof 5